AI assistant
Sanara MedTech Inc. — Director's Dealing 2013
Apr 12, 2013
33339_dirs_2013-04-12_40c819d8-b4e7-4243-a6a9-c44c6303a9c9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WOUND MANAGEMENT TECHNOLOGIES, INC. (WNDM)
CIK: 0000714256
Period of Report: 2012-07-13
Reporting Person: Rubinfeld Philip J (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-07-13 | Warrant | $0.15 | J | 100000 | Acquired | 2017-07-13 | Common (100000) | Direct |
| 2012-09-11 | Warrant | $0.15 | A | 18750 | Acquired | 2017-09-30 | Common (18750) | Direct |
Footnotes
F1: This warrant was issued in connection with a Subordinated Promissory note transaction pursuant to which Dr. Rubinfeld loaned the principal amount of $100,000 to the Company and acquired 100,000 warrants (1 warrant for every $1 of principal loaned) as part of the aforementioned transaction at no additional consideration.
F2: The board of directors of the Issuer (the "Board") approved the issuance of this warrant at a meeting of the Board on September 11, 2012 as compensation for Dr. Rubinfeld's service as a director on the Board of the Issuer.